NCT04176211Completed
The Impact of Myasthenia Gravis in the Real World
Source: ClinicalTrials.gov · Last updated 3 Jun 2024
Brief summary (registry, in English)
An international, non-interventional, prospective, community recruited, longitudinal, lifestyle study which aims to collect Real-World Evidence (RWE) from people living with myasthenia gravis (MG) in order to map the disease's natural history, its burden on patients and their families, its treatment, as well as its medical, social and pharmacoeconomic impact.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2847 (actual)
- First submitted
- 20 Nov 2019
- Start date
- 12 Dec 2019
- Primary completion date
- 31 May 2024
- Lead sponsor
- Vitaccess Ltd
- Diseases
- Myasthenia gravis
- NCT number
- NCT04176211
What you commit to
- Study type: Observational
- Participants enrolled: 2847
- From 12 Dec 2019 to the primary completion date, 31 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No specific exclusion criteria
Who the study is looking for
- Adults (aged 18 years and over) with any stage and any subtype of myasthenia gravis disease
- Resident in Belgium, Canada, France, Germany, Italy, Japan, Spain, the UK, the USA, or Denmark
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vitaccess Ltd Coordinator of this site? Confirm its status | Oxford | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.